Provided by Tiger Trade Technology Pte. Ltd.

PHARMARON

18.530
+0.7304.10%
Volume:5.17M
Turnover:94.73M
Market Cap:33.91B
PE:18.29
High:18.630
Open:17.800
Low:17.400
Close:17.800
52wk High:30.120
52wk Low:10.323
Shares:1.83B
HK Float Shares:353.00M
Volume Ratio:1.07
T/O Rate:1.47%
Dividend:0.22
Dividend Rate:1.18%
EPS(LYR):1.013
ROE:9.66%
ROA:4.91%
PB:2.05
PE(LYR):18.29
PS:2.21

Loading ...

HK Stock Connect Shareholding Changes | November 12

Stock News
·
Nov 12, 2025

HK Stock Connect Shareholding Changes | Nov 11

Stock News
·
Nov 11, 2025

Norges Bank Increases Stake in PHARMARON (03759) by 518,200 Shares at HK$25.76 per Share

Stock News
·
Nov 05, 2025

Pharmaron Beijing Co., Ltd. (03759) Announces October 2025 Share Capital and Movements Update

Bulletin Express
·
Nov 05, 2025

PHARMARON (03759) Shareholder Lou Xiaoqiang Pledges 2.154 Million Company Shares

Stock News
·
Nov 03, 2025

Goldman Sachs Raises PHARMARON (03759) Target Price to HK$30, Q3 Revenue Slightly Beats Expectations

Stock News
·
Nov 03, 2025

November 2025 Hong Kong Stock Market Investment Strategy and Top 10 Stock Picks

Stock News
·
Nov 02, 2025

CLSA Raises Pharmaron (03759) Target Price to HK$28.8, Maintains "Outperform" Rating

Stock News
·
Oct 31, 2025

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31, 2025

UBS: Pharmaron (03759) Sees Accelerated New Order Growth in First Three Quarters, Raises Target Price to HK$32.9, Maintains "Buy" Rating

Stock News
·
Oct 30, 2025

Pharmaron Beijing Co., Ltd.: Nomination Committee Terms of Reference Announced

Bulletin Express
·
Oct 28, 2025

Pharmaron Beijing Co., Ltd. Announces Remuneration and Appraisal Committee Terms of Reference

Bulletin Express
·
Oct 28, 2025

Pharmaron Beijing Updates Audit Committee Terms of Reference

Bulletin Express
·
Oct 28, 2025

PHARMARON (03759) Nominates Professor Zeng Jinfeng as Candidate for Independent Non-Executive Director

Stock News
·
Oct 28, 2025

Pharmaron Beijing (3759) Reports Independent Director Resignation, By-Election Plan, and Proposed Articles Amendments

Bulletin Express
·
Oct 28, 2025

Pharmaron (3759) Releases 2025 Third Quarterly Results, Reports Solid Growth in Revenue

Bulletin Express
·
Oct 28, 2025

Pharmaron Beijing (3759) Announces Acquisition of 82.54% Stake in Biortus

Bulletin Express
·
Oct 28, 2025

PHARMARON (03759) Reports Q1-Q3 Results: Net Profit Attributable to Shareholders Drops 19.76% YoY to RMB1.141 Billion

Stock News
·
Oct 28, 2025

HK Pharma Stocks Rose; WUXI XDC And WUXI AppTec Up 7%; HBM Holdings Up 6%; Hengrui Pharma And JW Therap Up 4%

Tiger Newspress
·
Oct 27, 2025

Hong Kong Stocks in Focus | PHARMARON (03759) Surges Over 5% After Signing Cooperation Framework Agreement with CityU

Stock News
·
Oct 24, 2025